| 序号 |
商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型 |
规格 |
参比药物 |
参比标准 |
申请号批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| 1 |
TOFACITINIB CITRATE |
216001 |
1 |
ANDA |
TOFACITINIB CITRATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 11MG BASE |
No |
No |
2025-09-30 |
2025-09-30 |
SINOTHERAPEUTICS INC |
Prescription |
| 2 |
MIFEPRISTONE |
216616 |
1 |
ANDA |
MIFEPRISTONE |
TABLET;ORAL |
200MG |
No |
No |
2025-09-30 |
2025-09-30 |
EVITA SOLUTIONS |
Prescription |
| 3 |
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE |
217735 |
1 |
ANDA |
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
SUSPENSION/DROPS;OTIC |
1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML |
No |
No |
2025-09-30 |
2025-09-30 |
AMNEAL |
Prescription |
| 4 |
RHAPSIDO |
218436 |
1 |
NDA |
REMIBRUTINIB |
TABLET;ORAL |
25MG |
Yes |
Yes |
2025-09-30 |
2025-09-30 |
NOVARTIS |
Prescription |
| 5 |
LEVONORGESTREL |
219102 |
1 |
ANDA |
LEVONORGESTREL |
TABLET;ORAL |
1.5MG |
No |
No |
2025-09-30 |
2025-09-30 |
ANNORA PHARMA |
Over-the-counter |
| 6 |
CALCIUM CHLORIDE 10% |
217463 |
1 |
ANDA |
CALCIUM CHLORIDE |
INJECTABLE;INJECTION |
100MG/ML |
No |
No |
2025-09-29 |
2025-09-29 |
SQUARE PHARMS PLC |
Prescription |
| 7 |
CALCITONIN-SALMON |
216294 |
1 |
ANDA |
CALCITONIN SALMON |
INJECTABLE;INJECTION |
200 IU/ML |
No |
No |
2025-09-26 |
2025-09-26 |
AMNEAL |
Prescription |
| 8 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE |
217398 |
1 |
ANDA |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
12.5MG;20MG |
No |
No |
2025-09-26 |
2025-09-26 |
MSN |
Prescription |
| 9 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE |
217398 |
2 |
ANDA |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
12.5MG;40MG |
No |
No |
2025-09-26 |
2025-09-26 |
MSN |
Prescription |
| 10 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE |
217398 |
3 |
ANDA |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
25MG;40MG |
No |
No |
2025-09-26 |
2025-09-26 |
MSN |
Prescription |